Biogen Long-term marketable securities increased by 7.8% to $465.60M in Q1 2026 compared to the prior quarter. Over 5 years (FY 2020 to FY 2025), Long-term marketable securities shows a downward trend with a -11.0% CAGR.
An increase indicates a long-term capital preservation strategy, while a decrease suggests the liquidation of long-term investments to fund operations or debt repayment.
This represents long-term investments in debt securities that the company intends to hold for more than one year. These...
Used by mature companies with strong cash flows to manage long-term liquidity and investment returns.
non_current_assets_available_for_sale_securities_debt_se_908f76| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q4 '24 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $915.10M | $968.30M | $892.00M | $1.00B | $1.10B | $860.30M | $705.70M | $978.20M | $1.21B | $100.00K | $0.00 | $0.00 | $431.90M | $465.60M |
| QoQ Change | — | +5.8% | -7.9% | +12.3% | +10.1% | -22.0% | -18.0% | +38.6% | +23.5% | -100.0% | -100.0% | — | — | +7.8% |
| YoY Change | — | — | — | — | +20.5% | -11.2% | -20.9% | -2.3% | +9.5% | -100.0% | -100.0% | — | — | — |